A Meta-Analysis of Cognitive-Behavioral Therapy for Alcohol or Other Drug Use Disorders: Treatment Efficacy by Contrast Condition
Open accessAbstract
OBJECTIVE: This meta-analysis examined 30 randomized controlled trials (32 study sites; 35 study arms) that tested the efficacy of cognitive-behavioral therapy (CBT) for alcohol or other drug use disorders. The study aim was to provide estimates of efficacy against three levels of experimental contrast (i.e., minimal [k = 5]; nonspecific therapy [k = 11]; specific therapy [k = 19]) for consumption frequency and quantity outcomes at early (1 to 6 months [kes = 41]) and late (8+ months [kes = 26]) follow-up time points. When pooled effect sizes were statistically heterogeneous, study-level moderators were examined. METHOD: The inverse-variance weighted effect size was calculated for each study and pooled under random effects assumptions. Sensitivity analyses included tests of heterogeneity, study influence, and publication bias. RESULTS: CBT in contrast to minimal treatment showed a moderate and significant effect size that was consistent across outcome type and follow-up. When CBT was contrasted with a nonspecific therapy or treatment as usual, treatment effect was statistically significant for consumption frequency and quantity at early, but not late, follow-up. CBT effects in contrast to a specific therapy were consistently nonsignificant across outcomes and follow-up time points. Of 10 pooled effect sizes examined, two showed moderate heterogeneity, but multivariate analyses revealed few systematic predictors of between-study variance. CONCLUSIONS: The current meta-analysis shows that CBT is more effective than a no treatment, minimal treatment, or nonspecific control. Consistent with findings on other evidence-based therapies, CBT did not show superior efficacy in contrast to another specific modality. (PsycINFO Database Record (c) 2019 APA, all rights reserved).
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 30 cited sources checked · 0 supported · 0 flagged
- Findingown data
CBT effects in contrast to a specific therapy were consistently non-significant across outcomes and follow-up time points.
“CBT effects in contrast to a specific therapy were consistently non-significant across outcomes and follow-up time points.”
Quote in the paperSubstantial claim - Findingown data
When CBT was contrasted with non-specific therapy or treatment as usual, treatment effect was not statistically significant at late follow-up.
“When CBT was contrasted with a non-specific therapy or treatment as usual, treatment effect was statistically significant for consumption frequency and quantity at early, but not late, follow-up.”
Quote in the paperSubstantial claim - Findingown data
Of ten pooled effect sizes examined, two showed moderate heterogeneity.
“Of ten pooled effect sizes examined, two showed moderate heterogeneity, but multivariate analyses revealed few systematic predictors of between-study variance.”
Quote in the paperNot a substantial claim - Findingown data
When CBT was contrasted with non-specific therapy or treatment as usual, treatment effect was statistically significant for consumption frequency and quantity at early follow-up.
“When CBT was contrasted with a non-specific therapy or treatment as usual, treatment effect was statistically significant for consumption frequency and quantity at early, but not late, follow-up.”
Quote in the paperSubstantial claim - Findingown data
Multivariate analyses revealed few systematic predictors of between-study variance.
“Of ten pooled effect sizes examined, two showed moderate heterogeneity, but multivariate analyses revealed few systematic predictors of between-study variance.”
Quote in the paperNot a substantial claim
- Findingown data
For non-specific therapy contrast conditions, only one study provided late follow-up quantity data (Kivlahan et al., 1990).
“and only one study provided late follow-up quantity data (Kivlahan et al., 1990)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Kivlahan et al., 1990
Not checked in the free run.
- Findingown data
The specific therapy contrast characterized the majority of studies reviewed.
“As noted above, this type of contrast characterized the majority of studies reviewed”
Quote in the paperNot a substantial claim - Findingown data
The pattern of larger quantity than frequency effects held for minimal and non-specific therapy contrasts.
“This pattern of findings held for minimal and non-specific therapy contrasts”
Quote in the paperNot a substantial claim - Findingown data
Quantity outcomes (19 effect sizes) were reported less consistently than frequency outcomes (47 effect sizes).
“although quantity outcomes (kes = 19) were reported less consistently than frequency outcomes (kes = 47)”
Quote in the paperSubstantial claim - Findingown data
Reporting of therapist training (44%), supervision frequency and/or methods (70%), and fidelity (7%) was variable in the sample of studies.
“However, reporting of therapist training (44%), supervision frequency and/or methods (70%), and fidelity (7%) was variable in the sample of studies.”
Quote in the paperSubstantial claim - Findingown data
For minimal contrast conditions, only one study provided late follow-up quantity data (Kivlahan et al., 1990).
“but only one study provided late follow-up quantity data (Kivlahan, Marlatt, Fromme, Coppel, & Williams, 1990)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Kivlahan, Marlatt, Fromme, Coppel, & Williams, 1990
Not checked in the free run.
- Findingown data
For minimal contrast conditions, the pooled effect size for quantity outcomes at early follow-up was moderate and significant, g = .67 (95% CI .41, .98, p < .001; tau2 = .00; I2 = 0%; k = 2).
“For quantity outcomes at early follow-up, the pooled effect size for two studies was moderate and significant (g = .67: 95% CI= .41, .98, p < .001; tau2 = .00, Q > .05, I2 = 0%; k = 2)”
Quote in the paperNot a substantial claim - Findingown data
For studies using no treatment or minimal treatment contrast, frequency outcomes showed CBT effects were quite durable, with moderate effects at both early (k = 5) and late (k = 4) follow-ups.
“In these cases, studies reporting frequency outcomes demonstrated that CBT effects were quite durable with moderate effects at both early (k = 5) and late (k = 4) follow-ups.”
Quote in the paperSubstantial claim- Rests on an assumption: Studies using a no treatment or minimal treatment contrast provide the optimal conditions for examining the durability of treatment effect.
- Findingown data
Non-significant pooled effects in contrast to a specific therapy were observed across outcome types and follow-up time points in the present study.
“Non-significant pooled effects, in contrast to a specific therapy, across outcome types and follow-up time point was observed in the present study.”
Quote in the paperSubstantial claim - Findingown data
For the heterogeneous effect of CBT on early follow-up use frequency in contrast to non-specific therapy, meta-regression yielded largely non-significant estimates, with the exception of client age.
“These analyses yielded largely non-significant meta-regression estimates, with the exception of client age.”
Quote in the paperNot a substantial claim - Findingown data
For the most part (8 of 10 subgroup estimates), the subgroup estimates showed acceptable homogeneity.
“For the most part (k = 8/10), these subgroup estimates showed acceptable homogeneity.”
Quote in the paperSubstantial claim - Findingown data
For CBT effects on early follow-up use frequency in contrast to non-specific therapy, older age was associated with smaller effect sizes (b = −.072, p = .044).
“older age was associated with smaller effect sizes (b = −.072, p = .044)”
Quote in the paperNot a substantial claim - Findingown data
For another specific therapy contrast, the pooled effect size for quantity outcomes was non-significant at early follow-up, g = .01 (95% CI −.11, .12, p = .956; tau2 = .01; I2 = 36%; k = 8).
“For quantity outcomes, pooled effects were also non-significant at early (g = .01: 95% CI = −.11, .12, p = .956; tau2 = .01, Q > .05, I2 = 36%; k = 8)”
Quote in the paperNot a substantial claim - Findingown data
For another specific therapy contrast, the pooled effect size for quantity outcomes was non-significant at late follow-up, g = .01 (95% CI −.09, .11, p = .887; tau2 = .00; I2 = 0%; k = 5).
“and late (g = .01: 95% CI = −.09, .11, p = 887; tau2 = .00, Q > .05, I2 = 0%; k = 5) follow-ups.”
Quote in the paperNot a substantial claim - Findingown data
Converting the effect estimates to a percentile success rate, 15% to 26% of CBT participants in minimal contrast studies had better outcomes than the median of those in minimal treatment conditions.
“the data show 15 to 26% of CBT participants had better outcomes than the median of those in minimal treatment conditions”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Cohen, 1988
Not checked in the free run.
- Findingown data
For non-specific therapy contrast conditions, the pooled effect size for frequency outcomes at late follow-up was non-significant, g = .05 (95% CI −.09, .19, p = .492; tau2 = .00; I2 = 0%; k = 7).
“However, the effect was non-significant at late follow-up (g = .05: 95% CI = −.09, .19, p = .492; tau2 = .00, Q > .05, I2 = 0%; k = 7).”
Quote in the paperSubstantial claim - Findingown data
A minority of early follow-up and late follow-up studies provided effect estimates prior to 6 and 12 months, respectively.
“Further, a minority of early follow-up (Carroll et al., 1991; Smout et al., 2010; Papas et al., 2011; Stephens, Roffman, & Simpson, 2000) and late follow-up (Dawe, Rees, Mattick, Sitharthan, & Heather, 2002; Thornton, Gottheil, Patkar, & Weinstein, 2003) studies provided effect estimates prior to 6 and 12 months, respectively.”
Quote in the paperSubstantial claim - Findingown data
For another specific therapy contrast, the pooled effect size for frequency outcomes was non-significant at early follow-up, g = −.02 (95% CI −.12, .08, p = .740; tau2 = .01; I2 = 14%; k = 16).
“The pooled effect size for frequency outcomes was non-significant at early (g = −.02: 95% CI = −.12, .08, p = .740; tau2 = .01, Q > .05, I2 = 14%; k = 16)”
Quote in the paperNot a substantial claim - Findingown data
In this review, non-specific contrasts were typically either treatment as usual or conditions designed to account for non-specific therapy factors.
“In this review, non-specific contrasts were typically either treatment as usual (e.g., Bowen et al., 2014; McKay et al., 2010; Morgenstern, Blanchard, Morgan, Labouvie, & Havaki, 2001; Papas et al., 2011) or conditions designed to account for non-specific therapy factors”
Quote in the paperNot a substantial claim - Findingown data
Relative durability in contrast to another form of treatment was not demonstrated in the present review.
“This relative durability was not demonstrated in the present review.”
Quote in the paperSubstantial claim - Findingown data
For non-specific therapy contrast conditions, the pooled effect size for quantity outcomes at early follow-up was moderate and significant for two studies, g = .42 (95% CI .03, .81, p = .034; tau2 = .00; I2 = 0%).
“For quantity outcomes at early follow-up, the pooled effect was moderate and significant for two studies (g = .42: 95% CI = .03, .81, p = .034; tau2 = .00, Q > .05, I2 = 0%)”
Quote in the paperNot a substantial claim - Findingown data
The majority of trials in this review considered CBT in contrast to an active comparison, either a non-specific or a specific therapy.
“However, the majority of trials in this review considered CBT in contrast to an active comparison, either a non-specific or a specific therapy.”
Quote in the paperSubstantial claim - Findingown data
For another specific therapy contrast, the pooled effect size for frequency outcomes was non-significant at late follow-up, g = −.04 (95% CI −.15, .08, p = .507; tau2 = .01; I2 = 15%; k = 8).
“and late (g = −.04: 95% CI = −.15, .08, p = .507; tau2 = .01, Q > .05, I2 = 15%; k = 8) follow-ups.”
Quote in the paperNot a substantial claim - Findingown data
When non-specific therapies or usual care were the contrast, the pooled effect size was small to non-significant.
“When non-specific therapies or usual care were the contrast, the pooled effect size was small to non-significant.”
Quote in the paperSubstantial claim - Findingown data
For minimal contrast conditions, the pooled effect size for frequency outcomes at late follow-up (8+ months) was g = .44 (95% CI .02, .86, p = .039; tau2 = .00; I2 = 0%; k = 2).
“g = .44 (95% CI = .02, .86, p = .039; tau2 = .00, Q > .05, I2 = 0%; k = 2) at late follow-up”
Quote in the paperNot a substantial claim - Findingown data
In the present study, estimates of effect were sizable only among the seven studies contrasting CBT with a minimal comparison.
“In the present study, estimates of effect were sizable only among the seven studies contrasting CBT with a minimal comparison.”
Quote in the paperSubstantial claim - Findingown data
Only one study explicitly targeted substance use moderation (Heather et al., 2000).
“and only one study explicitly targeted substance use moderation (Heather et al., 2000)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Heather et al., 2000
Not checked in the free run.
- Findingown data
For minimal, waitlist, or assessment-only contrast conditions, the pooled effect size for frequency outcomes at early follow-up (1-6 months) was g = .58 (95% CI .15, 1.01, p = .009; tau2 = .11; I2 = 59%; k = 4).
“the pooled effect size for frequency outcomes was g = .58 (95% CI = .15, 1.01, p = .009; tau2 = .11, Q > .05, I2 = 59%; k = 4) at early follow-up”
Quote in the paperSubstantial claim - Findingown data
In the present study, CBT effect sizes for quantity outcomes were larger than those for frequency outcomes, such as number of abstinent days.
“In the present study, CBT effect sizes for quantity outcomes were larger than frequency outcomes, such as number of abstinent days.”
Quote in the paperNot a substantial claim - Interpretationown data
CBT did not show superior efficacy in contrast to another specific modality.
“Consistent with findings on other evidence-based therapies, CBT did not show superior efficacy in contrast to another specific modality.”
Quote in the paperSubstantial claim - Premisecitation
The last meta-analysis of CBT efficacy for substance use was conducted 10 years ago.
“Despite its widespread application, the last meta-analysis of CBT efficacy for substance use was conducted 10 years ago (i.e., Magill & Ray, 2009).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Magill & Ray, 2009
Not checked in the free run.
- Interpretationreasoning
The current study can provide only preliminary data on the broader question of whether CBT is particularly effective for certain types of clinical outcomes.
“The current study can thus provide only preliminary data on the broader question of whether CBT is particularly effective for certain types of clinical outcomes.”
Quote in the paperSubstantial claim - Interpretationown data
The selected variables were informative effect size modifiers for the sample of clinical trials reviewed.
“This suggests that the selected variables were informative effect size modifiers for the sample of clinical trials reviewed.”
- Also stated in: § Conclusion · hedged
“The majority of derived effects were homogeneous, suggesting that the selected subgroup variables (i.e., contrast type, outcome type, and follow-up time point) were informative modifiers of CBT effects5.”
Quote in the paperSubstantial claim - Also stated in: § Conclusion · hedged
- Premisecitation
Irvin and colleagues (1999) reported effect sizes for secondary outcomes (e.g., self-efficacy or coping skills) that were more than twice the magnitude of those for substance use.
“Irvin and colleagues (1999) reported effect sizes for secondary outcomes (e.g., self-efficacy or coping skills) that were more than twice the magnitude of those for substance use.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Irvin et al., 1999
Not checked in the free run.
- Study design and conductown data
For non-specific therapy contrast studies, the plot did not suggest bias due to publication status (τ = .36, p = .059).
“does not suggest bias due to publication status (τ = .36, p = .059)”
Quote in the paperNot a substantial claim - Study design and conductown data
For minimal contrast studies, rank correlation analyses did not suggest bias due to publication status (τ = −.33, p = .497).
“rank correlation analyses do not suggest bias due to publication status (τ = −.33, p = .497)”
Quote in the paperNot a substantial claim - Study design and conductown data
Analyses by minimal contrast showed no influential studies.
“Analyses by minimal contrast showed no influential studies.”
Quote in the paperNot a substantial claim - Interpretationown data
Modest relative efficacy in contrast to non-specific conditions underscores how little is known about the specificity of CBT ingredients when delivered to populations with alcohol or other drug use disorders.
“Modest relative efficacy in contrast to these conditions underscores how little we know about the specificity of CBT ingredients when delivered to populations with alcohol or other drug use disorders.”
Quote in the paperSubstantial claim - Interpretationreasoning
The measure of efficacy in the CBT literature has most often been how well CBT performs in reference to another form of therapy.
“In other words, the measure of efficacy in the CBT literature has most often been how well CBT performs in reference to another form of therapy.”
Quote in the paperSubstantial claim - Premisecitation
Magill and Ray (2009) reported an overall effect size of g = .15, p < .005, for CBT.
“In 2009, Magill and Ray followed up this work with a meta-analysis of 53 experimental CBT studies, reporting a similar overall effect size (g = .15, p < .005), although findings related to superior effects with alcohol use disorder were not replicated.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Magill & Ray, 2009
Not checked in the free run.
- Interpretationreasoning
The quality of CBT delivery cannot be assured.
“As such, the quality of CBT-delivery cannot be assured.”
Quote in the paperSubstantial claim - Interpretationown data
Contrast condition matters when intervention effect magnitude is of interest.
“Perhaps the most important message of this meta-analysis, in concert with others in the literature, is that contrast condition matters when intervention effect magnitude is of interest”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Wampold, 1997
Not checked in the free run.
- cites Wampold, Minami, Baskin, & Tierney, 2002
Not checked in the free run.
- Interpretationreasoning
The findings in the present study reflect maintenance of CBT effects at follow-up rather than initial efficacy at post-treatment.
“This underscores the nature of findings in the present study as maintenance of CBT effects at follow-up, rather than initial efficacy at post-treatment.”
Quote in the paperSubstantial claim - Interpretationown data
In the present study, a moderate-to-large and stable effect size was observed for CBT in contrast to no treatment or a minimal treatment comparison (15-26% success rate).
“In the present study, a moderate-to-large and stable (i.e., across outcome type and follow-up time point) effect size was observed for CBT in contrast to no treatment or a minimal treatment comparison (15–26% success rate).”
- Also stated in: § Conclusion · plain
“In conclusion, this meta-analysis shows CBT efficacy, in contrast to no or minimal treatment, was moderate and durable over follow-up.”
Quote in the paperSubstantial claim - Also stated in: § Conclusion · plain
- Interpretationreasoning
Including studies of CBT combined with another psychosocial or pharmacological intervention could obscure effect size estimation for contrast type, outcome type, and follow-up.
“These latter topics are worthy of meta-analysis in their own right, and including such studies could obscure effect size estimation for the effect modifying factors of primary interest to this study: 1) CBT efficacy by contrast type (i.e., minimal; non-specific therapy; specific therapy), 2) CBT efficacy by consumption outcome type (i.e., frequency; quantity) and 3) CBT efficacy at early (i.e., 1–”
Quote in the paperSubstantial claim
- May combine two claims. 16
- Classified as probably not a substantial claim. 20
May combine two claims.
Findingown dataThe final meta-analytic sample included 30 studies, 32 study sites, and 5,398 participants.
“The final meta-analytic sample was comprised of K = 30 studies, with 32 study sites (i.e., two studies provided two sites each, Project MATCH Research Group, 1997; McAuliffe, 1990), and a total of 5,398 participants.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe meta-analysis examined 30 randomized controlled trials, 32 study sites, and 35 study arms testing CBT for alcohol or other drug use disorders.
“This meta-analysis examined 30 randomized controlled trials (32 study sites; 35 study arms) that tested the efficacy of cognitive-behavioral therapy (CBT) for alcohol or other drug use disorders (AUD/SUD).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataCBT in contrast to minimal treatment showed a moderate and significant effect size that was consistent across outcome type and follow-up.
“CBT in contrast to minimal treatment showed a moderate and significant effect size that was consistent across outcome type and follow-up.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataTwo of 10 pooled effect sizes had sufficient systematic heterogeneity to warrant moderator analyses (I2 range 45-59%), and only one of these two subgroups had enough studies to provide variability in the covariates examined.
“two out of 10 pooled effect sizes were determined to have sufficient systematic heterogeneity to warrant moderator analyses. Of these two estimates (I2 range = 45 – 59%), only one subgroup also contained a sufficient k number of studies to provide variability in the covariates examined.”
- Also stated in: § Limitations · plain
“In this study, two of 10 subgroup effect sizes showed greater than 40% systematics heterogeneity, and one of these two subgroups had a sufficient number of studies to allow multivariate moderator analysis.”
Quote in the paperSubstantial claim- Also stated in: § Limitations · plain
May combine two claims.
Findingown dataCBT effect sizes were small to non-significant in contrast to non-specific and specific therapies, respectively.
“Consistent with a number of evidence-based addictions therapies, CBT effect sizes were small to non-significant in contrast to non-specific and specific therapies, respectively.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataFor non-specific therapy contrast conditions, the pooled effect size for frequency outcomes at early follow-up was small and statistically significant, g = .18 (95% CI .02, .35, p = .04; tau2 = .03; I2 = 45%; k = 9), with a success rate roughly 8% higher than the median within the contrast condition.
“The pooled effect size for frequency outcomes at early follow-up was small and statistically significant (g = .18: 95% CI = .02, .35, p = .04; tau2 = .03, Q > .05, I2 = 45%; k = 9)6 with a success rate roughly 8% higher than the median within the contrast condition.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe derived effect sizes showed minimal heterogeneity, and when heterogeneity was observed, moderator analyses revealed few significant moderating factors, possibly due to low statistical power.
“In summary, the derived effect sizes showed minimal heterogeneity, and when heterogeneity was observed, moderator analyses revealed few significant moderating factors possibly due to low statistical power.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIrvin et al. (1999) reported a small overall effect size (r = .14, p < .05) for relapse prevention.
“They reported a small overall effect size (r = .14, p < .05), and suggested relapse prevention was more effective for alcohol use disorder than for other substances and when delivered in combination with a pharmacological intervention.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Irvin and colleagues (1999)
Not checked in the free run.
May combine two claims.
Interpretationown dataCBT is more effective than a no treatment, minimal treatment, or non-specific control.
“The current meta-analysis shows that CBT is more effective than a no treatment, minimal treatment, or non-specific control.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIn Magill and Ray (2009), effects for specific contrasts were small (g = .11, p < .05) and common (k = 17/53).
“In comparison, effects for non-specific contrasts (i.e., a passive, but time-matched or usual care control condition; e.g., treatment as usual, supportive therapy, drug counseling) and specific contrasts (i.e., another manualized therapy condition; e.g., Motivational Interviewing, Contingency Management) were small and more common in the literature (g =.15, p < .005, k = 32/53; g =.11, p < .05, k”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Magill & Ray, 2009
Not checked in the free run.
May combine two claims.
PremisecitationAddiction information, mutual support, and 12-step program involvement are established elements of community-based care and confer benefit in their own right.
“These are established elements of community-based care and confer benefit in their own right (SAMHSA, 2017).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites SAMHSA, 2017
Not checked in the free run.
May combine two claims.
PremisecitationIn Magill and Ray (2009), effects for non-specific contrasts were small (g = .15, p < .005) and common (k = 32/53).
“In comparison, effects for non-specific contrasts (i.e., a passive, but time-matched or usual care control condition; e.g., treatment as usual, supportive therapy, drug counseling) and specific contrasts (i.e., another manualized therapy condition; e.g., Motivational Interviewing, Contingency Management) were small and more common in the literature (g =.15, p < .005, k = 32/53; g =.11, p < .05, k”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Magill & Ray, 2009
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningThe cognitive-behavioral emphasis on relapse prevention suggests that CBT is well-suited to abstinence maintenance and long-term functioning.
“The cognitive-behavioral emphasis on relapse prevention suggests this is a treatment well-suited to abstinence maintenance and long-term functioning.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationPublication bias was assessed using rank correlation and graphical methods.
“Finally, to test for potential publication bias, the relationship between error and effect size was assessed using rank correlation (Begg & Mazumdar, 1994) and graphical methods (Egger, Smith, Schneider, & Minder, 1997).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Begg & Mazumdar, 1994
Not checked in the free run.
- cites Egger, Smith, Schneider, & Minder, 1997
Not checked in the free run.
Classified as probably not a substantial claim.
Interpretationown dataCaution is warranted about the quantity-outcome pattern because relatively fewer primary studies contributed quantity outcome effect estimates.
“but caution is warranted due to the relatively smaller number of primary studies contributing quantity outcome effect estimates.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenSensitivity analyses included tests of heterogeneity, study influence, and publication bias.
“Sensitivity analyses included tests of heterogeneity, study influence, and publication bias.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationAbstract screening was performed by two raters.
“Abstract screening occurred by two raters in ABSTRKR (Wallace, Small, Brodley, Lau, & Trikalinos, 2012).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIrvin et al. suggested relapse prevention was more effective for alcohol use disorder than for other substances.
“They reported a small overall effect size (r = .14, p < .05), and suggested relapse prevention was more effective for alcohol use disorder than for other substances and when delivered in combination with a pharmacological intervention.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Irvin and colleagues (1999)
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMagill and Ray's findings related to superior effects with alcohol use disorder were not replicated.
“In 2009, Magill and Ray followed up this work with a meta-analysis of 53 experimental CBT studies, reporting a similar overall effect size (g = .15, p < .005), although findings related to superior effects with alcohol use disorder were not replicated.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Magill & Ray, 2009
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationTrimmed estimates with influential studies removed were provided.
“Trimmed estimates with influential studies removed (Baujat, Mahé, Pignon, & Hill, 2002) were also provided.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Baujat, Mahé, Pignon, & Hill, 2002
Not checked in the free run.
Classified as probably not a substantial claim.
Study design and conductown dataIn this meta-analysis, two types of treatment outcomes were selected a priori: alcohol or other drug use frequency and quantity.
“In this meta-analysis, we selected two types of treatment outcomes a priori. These were alcohol or other drug use frequency and quantity.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationStudy-level risk-of-bias was assessed using Higgins et al. (2011).
“study-level risk-of-bias (Higgins et al., 2011).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Higgins et al., 2011
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationQualitative reviews reported mixed results on effect variability by primary drug type.
“Further, qualitative reviews have concluded that CBT is more effective than no treatment, but have reported mixed results on key questions such as efficacy over another evidence-based therapy (Longabaugh & Morgenstern, 1999), effect variability by primary drug type (Mastroleo & Monti, 2013; McHugh, Hearon, & Otto, 2010), and the optimal timing of intervention effects (Carroll & Onken, 2005).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Mastroleo & Monti, 2013
Not checked in the free run.
- cites McHugh, Hearon, & Otto, 2010
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationThe figure follows QUORUM guidelines.
“Figure 1 provides a visual representation of study inclusion for the present report on stand-alone CBT efficacy with adult AUD/SUD; the figure follows QUORUM guidelines (Moher et al., 1999).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Moher et al., 1999
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationOptimal outcomes could vary as a function of intervention modality, including specific ingredients and purported mechanisms of action.
“Further, optimal outcomes could vary as a function of intervention modality, including specific ingredients and purported mechanisms of action (Donovan et al., 2012).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Donovan et al., 2012
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationQualitative reviews reported mixed results on the optimal timing of intervention effects.
“Further, qualitative reviews have concluded that CBT is more effective than no treatment, but have reported mixed results on key questions such as efficacy over another evidence-based therapy (Longabaugh & Morgenstern, 1999), effect variability by primary drug type (Mastroleo & Monti, 2013; McHugh, Hearon, & Otto, 2010), and the optimal timing of intervention effects (Carroll & Onken, 2005).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Carroll & Onken, 2005
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenHeterogeneity and moderator analyses were considered two primary methods for examining effect size validity.
“We conducted sensitivity analyses throughout data analysis and considered heterogeneity and moderator analyses as two primary methods for examining effect size validity.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningA trade-off of the meta-analysis was that some effect estimates were based on a small number of primary studies, which could result in underpowered moderator analysis if heterogeneity was present.
“The trade-off was that some effect estimates were comprised of a small number of primary studies, which could result in underpowered moderator analysis if heterogeneity was present in these pooled effects.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductown dataAnalyses of CBT in contrast to a non-specific therapy showed three influential studies; when these were removed, the overall effect size became non-significant (trimmed g approximately .07 to .26).
“Analyses of CBT in contrast to a non-specific therapy showed three influential studies that, when removed, the overall effect size became non-significant (gtrimmed ~ .07 to .26).”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductown dataAnalyses of CBT in contrast to another specific therapy showed no influential studies and no evidence of publication bias (τ = .00, p = .500).
“Analyses of CBT in contrast to another specific therapy showed no influential studies and no evidence of publication bias (Figure 4; τ = .00, p = .500).”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIn Magill and Ray (2009), the effect of CBT over no treatment was large (g = .79, p < .005) but rare (k = 6/53).
“Specifically, the effect of CBT over no treatment was large (g =.79, p < .005), but this type of contrast was rare (k = 6/53).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Magill & Ray, 2009
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationQualitative reviews reported mixed results on CBT efficacy over another evidence-based therapy.
“Further, qualitative reviews have concluded that CBT is more effective than no treatment, but have reported mixed results on key questions such as efficacy over another evidence-based therapy (Longabaugh & Morgenstern, 1999), effect variability by primary drug type (Mastroleo & Monti, 2013; McHugh, Hearon, & Otto, 2010), and the optimal timing of intervention effects (Carroll & Onken, 2005).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Longabaugh & Morgenstern, 1999
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIrvin et al. suggested relapse prevention was more effective when delivered in combination with a pharmacological intervention.
“They reported a small overall effect size (r = .14, p < .05), and suggested relapse prevention was more effective for alcohol use disorder than for other substances and when delivered in combination with a pharmacological intervention.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Irvin and colleagues (1999)
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMeta-analyses of alcohol or other drug treatments generally show effect sizes in the small to moderate range.
“Meta-analyses of alcohol or other drug treatments generally show effect sizes in the small to moderate range”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Bertholet, Daeppen, Wietlisbach, Fleming, & Burnand, 2005
Not checked in the free run.
- cites Lundahl, Kunz, Brownell, Tollefson, & Burke, 2010
Not checked in the free run.
- cites Prendergast et al., 2002
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataData extraction was conducted in two independent passes by trained raters, with 95.3% between-rater agreement.
“Data were extracted in two independent passes conducted by trained raters (i.e., fourth and fifth authors), and showed a between-rater agreement rate of 95.3%.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
No CBT meta-analysis across substances or for individual substances had been conducted since Magill and Ray (2009).
“To our knowledge, this was the last CBT meta-analysis across substances, or for individual substances, conducted to date.”
The authors state this as an assumption.
Small sample and small effect studies characterize unpublished research.
“Here, small sample/small effect studies are assumed to characterize unpublished research, resulting in a significant and negative relationship, thus an asymmetrical funnel plot, when publication bias is present.”
The authors state this as an assumption.
The population effect size has an assumed distribution with both systematic and random sources of variability.
“In this approach, there is an assumed distribution for the population effect size with both systematic and random sources of variability (Hedges & Vevea, 1998).”
The paper relies on this without support.
This is the first meta-analysis of CBT efficacy for adults with alcohol and other drug use disorders conducted in 10 years.
“To our knowledge, this is the first meta-analysis of CBT efficacy for adults with alcohol and other drug use disorders conducted in 10 years, despite ongoing research and utilization of the CBT approach.”
The paper relies on this without support.
Studies using a no treatment or minimal treatment contrast provide the optimal conditions for examining the durability of treatment effect.
“Studies using a no treatment or a minimal treatment contrast provide the optimal conditions for examining the durability of treatment effect.”
The paper relies on this without support.
There is limited evidence for differential efficacy between specific therapies (the dodo bird effect).
“despite the known phenomenon of limited evidence for differential efficacy between specific therapies (i.e., the dodo bird effect).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Evidence-based strategies including contingency management, cognitive-behavioral therapy, dialectical behavior therapy, motivational interviewing, acceptance and commitment therapy, and family-based interventions have demonstrated effectiveness in reducing substance use and enhancing treatment outcomes.
“Evidence-based strategies, including contingency management (CM), cognitive-behavioral therapy (CBT), dialectical behavior therapy (DBT), motivational interviewing (MI), acceptance and commitment therapy (ACT), and family-based interventions, have demonstrated their effectiveness in reducing substance use and enhancing treatment outcomes”
From Navigating the Complex Intersection of Substance Use and Psychiatric Disorders: A Comprehensive Review (2024) · cites this paper as [49]
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measuredWhen contrasted with any specific therapy, CBT's effects were consistently non-significant across outcomes and follow-up time points.
“However, when contrasted with any spe cific therapy, CBT's effects were consistently non- significant a- cross outcomes and follow- up time points 235 .”
From Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention (2023) · cites this paper as [235]
A meta-analysis of 30 randomized controlled trials found that CBT demonstrated a moderate and significant effect size compared to minimal treatment consistently across outcome types and follow-up periods.
“Compared to minimal treatment (waitlist, brief psychoeducation), CBT demonstrated a moderate and significant effect size consistently across outcome types and follow-up periods.”
From A Narrative Review of Current and Emerging Trends in the Treatment of Alcohol Use Disorder (2024) · cites this paper as [120]
In that meta-analysis, CBT compared to non-specific therapy showed significant effects on consumption frequency and quantity at early follow-up, but not at late follow-up.
“Contrast with non-specific therapy (supportive therapy, drug counseling) showed significant effects on consumption frequency and quantity at early follow-up, but not at late follow-up.”
From A Narrative Review of Current and Emerging Trends in the Treatment of Alcohol Use Disorder (2024) · cites this paper as [120]
In that meta-analysis, CBT effects compared to specific therapy (motivational interviewing, contingency management) were consistently non-significant across outcomes and follow-up times.
“However, CBT effects compared to specific therapy (motivational interviewing, contingency management) were consistently non-significant across outcomes and follow-up times”
From A Narrative Review of Current and Emerging Trends in the Treatment of Alcohol Use Disorder (2024) · cites this paper as [120]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Early minimal-follow-up k differs within Results and Discussion
MinorOne part of the paper reports 4 early minimal-contrast frequency studies, while another says frequency outcomes at early follow-up for no/minimal contrast came from 5 studies. These are the same contrast and outcome/timepoint description, so the counts do not match.
“the pooled effect size for frequency outcomes was g = .58 (95% CI = .15, 1.01, p = .009; tau2 = .11, Q > .05, I2 = 59%; k = 4) at early follow-up”
“Studies using a no treatment or a minimal treatment contrast provide the optimal conditions for examining the durability of treatment effect. In these cases, studies reporting frequency outcomes demonstrated that CBT effects were quite durable with moderate effects at both early (k = 5) and late (k = 4) follow-ups.”
No treatment/minimal count stated as seven in Discussion but five in Abstract
MinorThe Discussion says estimates were sizable only among seven studies contrasting CBT with a minimal comparison, whereas the Abstract lists minimal contrast as k = 5. The paper does not explain this change in denominator or whether one refers to studies and the other to study sites.
“In the present study, estimates of effect were sizable only among the seven studies contrasting CBT with a minimal comparison.”
“The study aim was to provide estimates of efficacy against three levels of experimental contrast (i.e., minimal [k = 5]; non-specific therapy [k = 11]; specific therapy [k = 19]) for consumption frequency and quantity outcomes at early (1 – 6 months [kes = 41]) and late (8+ months [kes = 26]) follow-up time points.”
Minimal-comparison study counts change in the discussion
MinorThe results report four early and two late studies for frequency outcomes with a minimal-treatment comparison. The discussion reports five early and four late studies for the same outcomes and comparison.
“the pooled effect size for frequency outcomes was g = .58 (95% CI = .15, 1.01, p = .009; tau2 = .11, Q > .05, I2 = 59%; k = 4) at early follow-up and g = .44 (95% CI = .02, .86, p = .039; tau2 = .00, Q > .05, I2 = 0%; k = 2) at late follow-up.”
“In these cases, studies reporting frequency outcomes demonstrated that CBT effects were quite durable with moderate effects at both early (k = 5) and late (k = 4) follow-ups.”
Outcome-type and follow-up totals differ
MinorThe abstract reports 41 early and 26 late effect sizes, totaling 67. The discussion reports 19 quantity and 47 frequency effect sizes, totaling 66, although these are the two stated ways of dividing the effect sizes.
“early (1 – 6 months [kes = 41]) and late (8+ months [kes = 26]) follow-up time points.”
“quantity outcomes (kes = 19) were reported less consistently than frequency outcomes (kes = 47)”
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,841 · see citing works
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722 · see citing works
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817 · see citing works
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955 · see citing works
SAUNDERS, J. B., AASLAND, O. G., BABOR, T. F., DE LA FUENTE, J. R., & GRANT, M. (1993) · Addiction · doi:10.1111/j.1360-0443.1993.tb02093.x · Cited by 13,482 · see citing works
Wasserman, S. S., Hedges, L. V., & Olkin, I. (1988) · Journal of Educational Statistics · doi:10.2307/1164953 · Cited by 10,347 · see citing works
Moher, D., Cook, D. J., Eastwood, S., Olkin, I., Rennie, D., & Stroup, D. F. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04149-5 · Cited by 4,826 · see citing works
The Efficacy of Cognitive Behavioral Therapy: A Review of Meta-analyses
Hofmann, S. G., Asnaani, A., Vonk, I. J. J., Sawyer, A. T., & Fang, A. (2012) · Cognitive Therapy and Research · doi:10.1007/s10608-012-9476-1 · Cited by 3,445 · see citing works
The empirical status of cognitive-behavioral therapy: A review of meta-analyses
Butler, A. C., Chapman, J. E., Forman, E. M., & Beck, A. T. (2006) · Clinical Psychology Review · doi:10.1016/j.cpr.2005.07.003 · Cited by 3,215 · see citing works
An Improved Diagnostic Evaluation Instrument for Substance Abuse Patients
McLellan, A. T., Luborsky, L. B., WOODY, G. E., & Brien, C. P. O. (1980) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198001000-00006 · Cited by 3,163 · see citing works
Fixed-and random-effects models in meta-analysis.
Hedges, L. V., & Vevea, J. L. (1998) · Psychological Methods · doi:10.1037/1082-989x.3.4.486 · Cited by 2,977 · see citing works
A Meta-Analytic Review of Psychosocial Interventions for Substance Use Disorders
Dutra, L., Stathopoulou, G., Basden, S. L., Leyro, T. M., Powers, M. B., & Otto, M. W. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06111851 · Cited by 1,287 · see citing works
A Meta-Analysis of Motivational Interviewing: Twenty-Five Years of Empirical Studies
Lundahl, B. W., Kunz, C., Brownell, C., Tollefson, D., & Burke, B. L. (2010) · Research on Social Work Practice · doi:10.1177/1049731509347850 · Cited by 1,086 · see citing works
BAUJAT, B., Mahé, C., Pignon, J., & Hill, C. (2002) · Statistics in Medicine · doi:10.1002/sim.1221 · Cited by 762 · see citing works
Comparison of extended versus brief treatments for marijuana use.
Stephens, R. S., Roffman, R. A., & Curtin, L. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.68.5.898 · Cited by 711 · see citing works
Bertholet, N. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.9.986 · Cited by 710 · see citing works
Bowen, S., Witkiewitz, K., Clifasefi, S. L., Grow, J., Chawla, N., Hsu, S. H., Carroll, H. A., Harrop, E., Collins, S. E., Lustyk, M. K., et al. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.4546 · Cited by 701 · see citing works
Magill, M., & Ray, L. A. (2009) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2009.70.516 · Cited by 694 · cited 4× · see citing works
“A decade later, Magill and Ray (2009) followed up this work with a meta-analysis of 53 experimental CBT studies, reporting a similar overall effect size (g .15, p .005), although findings related to superior effects with alcohol use disorder were not replicated.”
BackgroundInfluentialSelf-citationCognitive Behavioral Therapy for Substance Use Disorders
McHugh, R. K., Hearon, B. A., & Otto, M. W. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2010.04.012 · Cited by 626 · see citing works
Deploying an interactive machine learning system in an evidence-based practice center: abstrackr
Wallace, B. C., Small, K., Brodley, C. E., Lau, J., & Trikalinos, T. A. (2012) · Proceedings of the 2nd ACM SIGHIT International Health Informatics Symposium · doi:10.1145/2110363.2110464 · Cited by 532 · see citing works
Maisel, N. C., Blodgett, J. C., Wilbourne, P. L., Humphreys, K., & Finney, J. W. (2013) · Addiction · doi:10.1111/j.1360-0443.2012.04054.x · Cited by 470 · see citing works
Behavioral Therapies for Drug Abuse
Carroll, K. M., & Onken, L. S. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.8.1452 · Cited by 467 · see citing works
Self-citationEfficacy of relapse prevention: A meta-analytic review.
Irvin, J. E., Bowers, C. A., Dunn, M. E., & Wang, M. C. (1999) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.67.4.563 · Cited by 424 · see citing works
The effectiveness of drug abuse treatment: a meta-analysis of comparison group studies
PRENDERGAST, M. L., Podus, D., Chang, E. Y., & Urada, D. I. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00014-5 · Cited by 336 · see citing works
Secondary prevention with college drinkers: Evaluation of an alcohol skills training program.
Kivlahan, D. R., Marlatt, G. A., Fromme, K., Coppel, D. B., & al, E. (1990) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.58.6.805 · Cited by 335 · see citing works
A meta-(re) analysis of the effects of cognitive therapy versus ‘other therapies’ for depression
Wampold, B. E., Minami, T., Baskin, T. W., & Callen Tierney, S. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00287-1 · Cited by 305 · see citing works
Budney, A. J., Moore, B. A., Rocha, H. L., & Higgins, S. T. (2006) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.4.2.307 · Cited by 290 · see citing works
Matching alcoholics to coping skills or interactional therapies: Posttreatment results.
Kadden, R. M., Cooney, N. L., Getter, H., & Litt, M. D. (1989) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.57.6.698 · Cited by 289 · see citing works
Relapse prevention as a psychosocial treatment: A review of controlled clinical trials.
Carroll, K. M. (1996) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.4.1.46 · Cited by 285 · see citing works
Self-citationTreating adult marijuana dependence: A test of the relapse prevention model.
Stephens, R. S., Roffman, R. A., & Simpson, E. E. (1994) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.62.1.92 · Cited by 270 · see citing works
Carroll, K., Rounsaville, B., & Gawin, F. (1991) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952999109027549 · Cited by 264 · see citing works
Self-citationMedication-Assisted Treatment With Methadone: Assessing the Evidence
Fullerton, C. A., Kim, M. L., Parks, C. L., Lyman, D. R., Montejano, L. B., Dougherty, R. H., Daniels, A. S., Ghose, S. S., & Delphin-Rittmon, M. E. (2013) · Psychiatric Services · doi:10.1176/appi.ps.201300235 · Cited by 250 · see citing works
Kadden, R. M., Kathleen, C., Donovan, D. M., Cooney, N. L., Monti, P. M., Abrams, D. B., Litt, M. D., & Hester, R. K. (2003) · Cited by 241 · see citing works
Streeton, C. (2001) · Alcohol and Alcoholism · doi:10.1093/alcalc/36.6.544 · Cited by 228 · cited 1× · see citing works
“…dl y. Bertholet, Daeppen, Wietlisbach, Fleming, & Burnand, 2005; Lundahl, Kunz, Brownell, Tollefson, & Burke, 2010; Prendergast et al., 2002) and this includes pharmacological treatments (e.g., Fullerton et al., 2014; Maisel, Blodgett, Wilbourne, Humphreys, & Finney, 2013; Streeton & Whelan, 2001).”
Carroll, K. M., & Kiluk, B. D. (2017) · Psychology of Addictive Behaviors · doi:10.1037/adb0000311 · Cited by 218 · see citing works
Self-citationDonovan, D. M., Bigelow, G. E., Brigham, G. S., Carroll, K. M., Cohen, A. J., Gardin, J. G., Hamilton, J. A., Huestis, M. A., Hughes, J. R., Lindblad, R., et al. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03473.x · Cited by 208 · see citing works
Self-citationDistinctions without a difference: Direct comparisons of psychotherapies for alcohol use disorders.
Imel, Z. E., Wampold, B. E., Miller, S. D., & Fleming, R. (2008) · Psychology of Addictive Behaviors · doi:10.1037/a0013171 · Cited by 174 · see citing works
Cooper, H. M., & Hedges, L. V. (1994) · Journal of International Crisis and Risk Communication Research · Cited by 169 · see citing works
Maude-Griffin, P. M., Hohenstein, J. M., Humfleet, G. L., Reilly, P. M., Tusel, D. J., & Hall, S. M. (1998) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.66.5.832 · Cited by 162 · see citing works
Methodological Problems in Identifying Efficacious Psychotherapies
Wampold, B. E. (1997) · Psychotherapy Research · doi:10.1080/10503309712331331853 · Cited by 149 · see citing works
Tanner-Smith, E. E., Durlak, J. A., & Marx, R. A. (2018) · Prevention Science · doi:10.1007/s11121-018-0942-1 · Cited by 140 · see citing works
Smout, M. F., Longo, M., Harrison, S., Minniti, R., Wickes, W., & White, J. M. (2010) · Substance Abuse · doi:10.1080/08897071003641578 · Cited by 129 · see citing works
Cue exposure in moderation drinking: A comparison with cognitive-behavior therapy.
Sitharthan, T., Sitharthan, G., Hough, M. J., & Kavanagh, D. J. (1997) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.65.5.878 · Cited by 123 · see citing works
McKay, J. R., Alterman, A., Cacciola, J., Rutherford, M., O'Brien, C., & Koppenhaver, J. M. (1997) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.65.5.778 · Cited by 121 · see citing works
McKay, J., Lynch, K., Shepard, D., Ratichek, S. J., Morrison, R., Koppenhaver, J., & Pettinati, H. (2004) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.72.6.967 · Cited by 119 · see citing works
Papas, R. K., Sidle, J. E., Gakinya, B. N., Baliddawa, J. B., Martino, S., Mwaniki, M. M., Songole, R., Omolo, O. E., Kamanda, A. M., Ayuku, D. O., et al. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03518.x · Cited by 111 · see citing works
Self-citationLongabaugh, R., & Morgenstern, J. (1999) · PubMed Central · Cited by 104 · see citing works
Brief coping skills treatment for cocaine abuse: substance use outcomes at three months
MONTI, P. M., ROHSENOW, D. J., MICHALEC, E., MARTIN, R. A., & ABRAMS, D. B. (1997) · Addiction · doi:10.1111/j.1360-0443.1997.tb02892.x · Cited by 104 · see citing works
Lanza, P. V., García, P. F., Lamelas, F. R., & González‐Menéndez, A. (2014) · Journal of Clinical Psychology · doi:10.1002/jclp.22060 · Cited by 101 · see citing works
Morgenstern, J., Blanchard, K. A., Morgan, T. J., Labouvie, E. W., & Hayaki, J. (2001) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.69.6.1007 · Cited by 99 · see citing works
Magill, M., Kiluk, B. D., McCrady, B. S., Tonigan, J. S., & Longabaugh, R. (2015) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12848 · Cited by 88 · see citing works
Self-citationMethods for handling missing data in research synthesis.
Pigott, T. (1994) · Cited by 83 · see citing works
Kiluk, B. D., Fitzmaurice, G. M., Strain, E. C., & Weiss, R. D. (2018) · Addiction · doi:10.1111/add.14289 · Cited by 80 · see citing works
Self-citationMcAuliffe, W. E. (1990) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1990.10472544 · Cited by 75 · see citing works
Matching substance abuse aftercare treatments to client characteristics
Brown, T. G., Seraganian, P., Tremblay, J., & Annis, H. M. (2002) · Addictive Behaviors · doi:10.1016/s0306-4603(01)00195-2 · Cited by 65 · see citing works
Litt, M., Kadden, R., Tennen, H., & Kabela-Cormier, E. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.06.010 · Cited by 62 · see citing works
A randomized controlled trial of Moderation-Oriented Cue Exposure.
Heather, N., Brodie, J., Wale, S. P., Wilkinson, G., Luce, A., Webb, E., & McCarthy, S. (2000) · Journal of Studies on Alcohol · doi:10.15288/jsa.2000.61.561 · Cited by 60 · see citing works
Prospective matching of alcoholic clients to cognitive-behavioral or interactional group therapy.
Kadden, R. M., Litt, M. D., Cooney, N. L., Kabela, E., & Getter, H. (2001) · Journal of Studies on Alcohol · doi:10.15288/jsa.2001.62.359 · Cited by 47 · see citing works
McKay, J. R., Lynch, K. G., Coviello, D., Morrison, R., Cary, M. S., Skalina, L., & Plebani, J. (2010) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0018139 · Cited by 46 · cited 2× · see citing works
“In this review, nonspecific contrasts were typically either treatment as usual (e.g., Bowen et al., 2014; McKay et al., 2010; Morgenstern, Blanchard, Morgan, Labouvie, & Hayaki, 2001; Papas et al., 2011) or conditions designed to account for nonspecific therapy factors (e.g., supportive therapy…”
BackgroundEfficacy of moderation-oriented cue exposure for problem drinkers: A randomized controlled trial.
Dawe, S., Rees, V. W., Mattick, R. P., Sitharthan, T., & Heather, N. (2002) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.70.4.1045 · Cited by 44 · see citing works
Community‐based alcohol counselling: a randomized clinical trial
Shakeshaft, A. P., Bowman, J., Burrows, S., Doran, C. M., & Sanson‐Fisher, R. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00199.x · Cited by 38 · see citing works
Skill training with alcoholics: A clinical extension
Jones, S. L., Kanfer, R., & Lanyon, R. I. (1982) · Addictive Behaviors · doi:10.1016/0306-4603(82)90057-0 · Cited by 37 · see citing works
Out‐patient behaviour therapy in alcoholism: treatment outcome after 2 years
Burtscheidt, W., Wölwer, W., Schwarz, R., Strauß, W. H., & Gäebel, W. (2002) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2002.02332.x · Cited by 36 · see citing works
Meta-analyses in alcohol and other drug abuse treatment research
Wilson, D. B. (2000) · Addiction · doi:10.1080/09652140020004313 · Cited by 31 · see citing works
Cognitive behavioral relapse prevention strategies and aftercare in alcoholism rehabilitation.
Donovan, D. M., & Ito, J. R. (1988) · Psychology of Addictive Behaviors · doi:10.1037/h0080521 · Cited by 15 · see citing works
Sandahl, C., Gerge, A., & Herlitz, K. (2004) · Psychotherapy Research · doi:10.1093/ptr/kph032 · Cited by 13 · see citing works
The Effect of Coping Skills Training on Alcohol Consumption in Heavy Social Drinking
Källmén, H., Sjöberg, L., & Wennberg, P. (2003) · Substance Use & Misuse · doi:10.1081/ja-120017616 · Cited by 12 · see citing works
Coping Styles and Response to High versus Low‐Structure Individual Counseling for Substance Abuse
Thornton, C. C., Gottheil, E., Patkar, A. A., & Weinstein, S. P. (2003) · American Journal on Addictions · doi:10.1080/10550490390143330 · Cited by 4 · see citing works
Cognitive-behavioral treatment for addictions.
Mastroleo, N. R., & Monti, P. M. (2013) · Cited by 4 · see citing works
Flagged first, then by citations
2 of the 71 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Volkow, N. D., & Blanco, C. (2023) · World psychiatry · doi:10.1002/wps.21073 · Cited by 503 · see citing works
Leichsenring, F., Steinert, C., Rabung, S., & Ioannidis, J. P. A. (2022) · World Psychiatry · doi:10.1002/wps.20941 · Cited by 485 · see citing works
Ray, L. A., Meredith, L. R., Kiluk, B. D., Walthers, J., Carroll, K. M., & Magill, M. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.8279 · Cited by 265 · see citing works
Self-citationHazardous drinking and alcohol use disorders
MacKillop, J. M., Agabio, R., Ewing, S. W. F., Heilig, M. A., Kelly, J. F., Leggio, L., Lingford-Hughes, A. R., Palmer, A. A., Parry, C. D. H., Ray, L. A., et al. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00406-1 · Cited by 235 · see citing works
Self-citationCulturally Responsive Cognitive Behavioral Therapy for Ethnically Diverse Populations
Huey, S. J., Park, A. L., Galán, C. A., & Wang, C. X. (2023) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-080921-072750 · Cited by 160 · see citing works
Manning, V., Garfield, J. B. B., Staiger, P. K., Lubman, D. I., Lum, J. A. G., Reynolds, J., Hall, K., Bonomo, Y. A., Lloyd‐Jones, M., Wiers, R. W. H. J., et al. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.3446 · Cited by 109 · see citing works
Ginley, M. K., Pfund, R. A., Rash, C. J., & Zajac, K. (2021) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000552 · Cited by 108 · see citing works
Mechanisms of Behavior Change in Substance Use Disorder With and Without Formal Treatment
Witkiewitz, K. A., Pfund, R. A., & Tucker, J. A. (2022) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-072720-014802 · Cited by 102 · see citing works
Clinical management of the alcohol withdrawal syndrome
Day, E., & Daly, C. (2021) · Addiction · doi:10.1111/add.15647 · Cited by 87 · see citing works
Magill, M., Tonigan, J. S., Kiluk, B. D., Ray, L. A., Walthers, J., & Carroll, K. M. (2020) · Behaviour Research and Therapy · doi:10.1016/j.brat.2020.103648 · Cited by 85 · see citing works
Self-citationBahji, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13040999 · Cited by 83 · see citing works
Canadian Guideline for the Clinical Management of High-Risk Drinking and Alcohol Use Disorder
Wood, E., Bright, J., Hsu, K., Goel, N., Ross, J. W. G., Hanson, A., Teed, R., Poulin, G., Denning, B., Corace, K., et al. (2023) · Canadian Medical Association Journal · doi:10.1503/cmaj.230715 · Cited by 74 · see citing works
Alcohol use and dementia: new research directions
Visontay, R., Rao, R. T., & Mewton, L. R. (2020) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000679 · Cited by 67 · see citing works
Sahker, E., Pro, G. C., Sakata, M., & Furukawa, T. A. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108087 · Cited by 60 · see citing works
Zamboni, L., Centoni, F., Fusina, F., Mantovani, E., Rubino, F., Lugoboni, F., & Federico, A. (2021) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000001381 · Cited by 54 · see citing works
Identification and Treatment of Alcohol Use Disorder
Haber, P. (2025) · New England Journal of Medicine · doi:10.1056/nejmra2306511 · Cited by 53 · see citing works
Johansson, M., Sinadinovic, K., Gajecki, M., Lindner, P., Berman, A. H., Hermansson, U., & Andréasson, S. (2020) · Addiction · doi:10.1111/add.15270 · Cited by 52 · see citing works
Magill, M., Kiluk, B. D., & Ray, L. A. (2023) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s362864 · Cited by 50 · see citing works
“22 This raises a key point, which is that it is difficult to obtain a clinically-meaningful measure of CBT effect from the narrative review and meta-analytic literature because of the relative rarity of waitlist-controlled trials.”
Self-citationAlcohol use disorder in community management of chronic liver diseases
Leggio, L., & Mellinger, J. L. (2022) · Hepatology · doi:10.1002/hep.32531 · Cited by 50 · see citing works
Johansson, M., Berman, A. H., Sinadinovic, K., Lindner, P., Hermansson, U., & Andréasson, S. (2021) · Journal of Medical Internet Research · doi:10.2196/29666 · Cited by 46 · see citing works
Mastroleo, N. R., Humm, L. B., Williams, C. M., Kiluk, B. D., Hoadley, A., & Magill, M. (2020) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2020.108014 · Cited by 44 · see citing works
Self-citationPott, S. L., Delgadillo, J., & Kellett, S. (2021) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2021.108478 · Cited by 43 · see citing works
Boness, C. L., Votaw, V. R., Schwebel, F. J., Moniz-Lewis, D. I. K., McHugh, R. K., & Witkiewitz, K. A. (2023) · Clinical Psychology Science and Practice · doi:10.1037/cps0000131 · Cited by 42 · see citing works
Levinson, C. A., Christian, C., & Becker, C. B. (2024) · Clinical Psychological Science · doi:10.1177/21677026231217316 · Cited by 39 · see citing works
Cohen, S. M., Alexander, R. S., & Holt, S. R. (2021) · Medical Clinics of North America · doi:10.1016/j.mcna.2021.08.003 · Cited by 39 · see citing works
Toward a unifying theory of dysregulated behaviors
Bresin, K. (2020) · Clinical Psychology Review · doi:10.1016/j.cpr.2020.101885 · Cited by 38 · see citing works
Taubner, S., Ioannou, Y., Saliba, A., Sales, C. M. D., Volkert, J., Protić, S., Adler, A., Barkauskiene, R., Conejo-Cerón, S., Di Giacomo, D., et al. (2024) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-023-02186-9 · Cited by 36 · see citing works
Do psychosocial treatment outcomes vary by race or ethnicity? A review of meta-analyses
Cougle, J. R., & Grubaugh, A. L. (2022) · Clinical Psychology Review · doi:10.1016/j.cpr.2022.102192 · Cited by 36 · see citing works
Manning, V., Garfield, J. B. B., Reynolds, J., Staiger, P. K., Piercy, H., Bonomo, Y., Lloyd‐Jones, M., Jacka, D., Wiers, R. W., Verdejo‐Garcia, A., et al. (2022) · Addiction · doi:10.1111/add.15989 · Cited by 33 · see citing works
Targeting Unmet Clinical Needs in the Treatment of Alcohol Use Disorder
Lohoff, F. W. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.767506 · Cited by 33 · see citing works
Self-Efficacy as a Potential Mechanism of Behavior Change in Mindfulness-Based Relapse Prevention
Moniz-Lewis, D. I. K., Stein, E., Bowen, S. W., & Witkiewitz, K. A. (2022) · Mindfulness · doi:10.1007/s12671-022-01946-z · Cited by 34 · see citing works
Alavi, S. M. A., Irani, R. D., Fattahi, P., & Pakseresht, S. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-05413-4 · Cited by 30 · see citing works
Tucker, J. A., Buscemi, J., Murphy, J. G., Reed, D. D., & Vuchinich, R. E. (2022) · Psychology of Addictive Behaviors · doi:10.1037/adb0000845 · Cited by 30 · see citing works
Boness, C. L., & Witkiewitz, K. A. (2022) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000613 · Cited by 29 · see citing works
Bhattacharjee, A., Williams, J. J., Chou, K., Tomlinson, J., Meyerhoff, J., Mariakakis, A. T., & Kornfield, R. (2022) · Proceedings of the ACM on Human-Computer Interaction · doi:10.1145/3555123 · Cited by 29 · see citing works
Bel‐Bahar, T., Khan, A. A., Shaik, R., & Parvaz, M. A. (2022) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2022.995534 · Cited by 28 · see citing works
Disparities in Treatment for Alcohol Use Disorder Among All of Us Participants
Le, P., Rich, J. J., Bernstein, E. Y., Glass, J. E., Gasoyan, H., Back, S. E., Bui, T. C., Ayers, G. T., & Rothberg, M. B. (2024) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230730 · Cited by 28 · see citing works
Roos, C. R., Hedy Kober, A., Trull, T. J., MacLean, R. R., & Mun, C. J. (2020) · Current Addiction Reports · doi:10.1007/s40429-020-00329-5 · Cited by 28 · see citing works
Nadkarni, A., Massazza, A., Guda, R., Fernandes, L., Garg, A., Jolly, M., Andersen, L. S., Bhatia, U., Bogdanov, S., Roberts, B., et al. (2022) · Drug and Alcohol Review · doi:10.1111/dar.13550 · Cited by 28 · see citing works
Lipsett, M., Wyant-Stein, K., Mendes, S., Berger, E. L., Berkman, E. T., Terplan, M., & Cioffi, C. C. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1199661 · Cited by 28 · see citing works
Herman, M. A., & Quadir, S. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00170-5 · Cited by 26 · see citing works
Li, X., Kass, G., Wiers, C. E., & Shi, Z. (2024) · Current Addiction Reports · doi:10.1007/s40429-024-00593-9 · Cited by 26 · see citing works
The IARC Perspective on the Effects of Policies on Reducing Alcohol Consumption
Gapstur, S. M., Mariosa, D., Neamţiu, L., Nethan, S. T., Rehm, J. T., Huckle, T., Jernigan, D. H., O’Connor, E., Štelemėkas, M., Allebeck, P., et al. (2025) · New England Journal of Medicine · doi:10.1056/nejmsr2413289 · Cited by 26 · see citing works
Caneva, S., Ottonello, M., Torselli, E., Pistarini, C., Spigno, P., & Fiabane, E. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s254369 · Cited by 26 · see citing works
Alcohol Use Disorder in Older Adults
Fenollal-Maldonado, G., Brown, D. S., Hoffman, H. L., Kahlon, C. K., & Grossberg, G. T. (2021) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2021.07.006 · Cited by 26 · see citing works
Longitudinal associations between pain and substance use disorder treatment outcomes
Ferguson, E. G., Lewis, B., Teitelbaum, S. A., Reisfield, G. M., Robinson, M., & Boissoneault, J. (2022) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2022.108892 · Cited by 26 · see citing works
A Narrative Review of Current and Emerging Trends in the Treatment of Alcohol Use Disorder
Celik, M., Gold, M. S., & Fuehrlein, B. (2024) · Brain Sciences · doi:10.3390/brainsci14030294 · Cited by 25 · see citing works
Krotter, A., Diego, G. A., Menéndez, A. G., González‐Roz, A., Secades‐Villa, R., & Pérez, Á. G. (2024) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2024.100773 · Cited by 25 · see citing works
Ray, L. A., Du, H., Green, R., Roche, D. J. O., & Bujarski, S. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-00913-3 · Cited by 23 · see citing works
Self-citationStapinski, L. A., Sannibale, C., Subotic, M., Rapee, R. M., Teesson, M., Haber, P. S., & Baillie, A. J. (2021) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867420952539 · Cited by 22 · see citing works
Rehm, J. T., Assanangkornchai, S., Hendershot, C. S., Franklin, A., Neufeld, M., Hassan, A. S., & Shield, K. D. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01496-5 · Cited by 23 · see citing works
Efficacy and safety of psilocybin for the treatment of substance use disorders: A systematic review
Meshkat, S., Malik, G., Zeifman, R. J., Swainson, J., Balachandra, K., Reichelt, A. C., Zhang, Y., Burback, L., Winkler, O., Greenshaw, A. J., et al. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106163 · Cited by 21 · see citing works
Contingency management for drug use disorders: Meta-analysis and application of Tolin’s criteria.
Pfund, R. A., Ginley, M. K., Boness, C. L., Rash, C. J., Zajac, K., & Witkiewitz, K. A. (2022) · Clinical Psychology Science and Practice · doi:10.1037/cps0000121 · Cited by 21 · see citing works
Wen, H., Xiang, X., Jiang, Y., Zhang, H., Zhang, P., Chen, R., Wei, X., Dong, Y., Xiao, S., & Lu, L. (2023) · Addiction · doi:10.1111/add.16167 · Cited by 21 · see citing works
Roos, C. R., Carroll, K. M., Nich, C., Frankforter, T. L., & Kiluk, B. D. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108044 · Cited by 21 · see citing works
Self-citationA Digital Cognitive Behavioral Therapy Program for Adults With Alcohol Use Disorder
Kiluk, B. D., Benitez, B., DeVito, E. E., Frankforter, T. L., LaPaglia, D. M., O’Malley, S. S., & Nich, C. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.35205 · Cited by 20 · see citing works
Self-citationTolin, D. F., Grasso, D. J., Boness, C. L., Beck, J. G., Keane, T. M., Leichsenring, F., Olatunji, B. O., Otto, M. W., & Weinand, J. (2024) · Clinical Psychology Science and Practice · doi:10.1037/cps0000220 · Cited by 19 · see citing works
Characterizing the Variation of Alcohol Cessation Pharmacotherapy in Primary Care
Bernstein, E. Y., Guo, N., Goto, T., & Rothberg, M. B. (2021) · Journal of General Internal Medicine · doi:10.1007/s11606-020-06454-1 · Cited by 18 · see citing works
A Cognitive-Behavioral Formulation of Narcissistic Self-Esteem Dysregulation
Nook, E. C., Jaroszewski, A. C., Finch, E. F., & Choi-Kain, L. W. (2022) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20220055 · Cited by 17 · see citing works
Self-control, coping styles, and alcohol outcomes in college students
Lucke, H. R., Carey, C. N., Griffith, E. L., Mathes, E. W., Lane, D. J., & Boals, A. (2023) · Journal of American College Health · doi:10.1080/07448481.2022.2160260 · Cited by 17 · see citing works
A Review of Behavioral Therapies in Adolescents with Opioid Use Disorder
Welsh, J. W., Mataczynski, M. J., Nguyen, M. D., & McHugh, R. K. (2020) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000272 · Cited by 16 · see citing works
Guerrin, C. G. J., Tesselaar, D. R. M., Booij, J., Schellekens, A., & Homberg, J. R. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106311 · Cited by 15 · see citing works
The Effect of Cognitive Behavioral Therapy on Impulsivity in Addictive Disorders: a Narrative Review
Loya, J. M., Benitez, B., & Kiluk, B. D. (2023) · Current Addiction Reports · doi:10.1007/s40429-023-00491-6 · Cited by 15 · see citing works
Self-citationThaysen‐Petersen, D., Hammerum, S. K., Vissing, A.-C., Oestrich, I. H., Nordentoft, M., Düring, S. W., & Fink‐Jensen, A. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1337898 · Cited by 14 · see citing works
Núñez-Rodríguez, S., Burgos-González, D., Mínguez-Mínguez, L. A., Menéndez-Vega, F., Antoñanzas-Laborda, J. L., Gonzalez-Bernal, J. J., & González‐Santos, J. (2025) · European Journal of Investigation in Health Psychology and Education · doi:10.3390/ejihpe15040049 · Cited by 14 · see citing works
Zakaria, S., Sasagawa, S., & Essau, C. A. (2021) · Addictive Behaviors Reports · doi:10.1016/j.abrep.2021.100381 · Cited by 14 · see citing works
Hofstedt, A., Mide, M., Arvidson, E., Ljung, S., Lindskog, A., Mattiasson, J., & Gordh, A. S. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1162492 · Cited by 14 · see citing works
Daros, A. R., Guimond, T. H., Yager, C., Palermo, E. H., Wilks, C. R., & Quilty, L. C. (2023) · JMIR Mental Health · doi:10.2196/50399 · Cited by 14 · see citing works
van Amsterdam, J., Blanken, P., Spijkerman, R., van den Brink, W., & Hendriks, V. M. (2022) · Alcohol and Alcoholism · doi:10.1093/alcalc/agac043 · Cited by 14 · see citing works
Park, J. W., & Kim, H. S. (2021) · Journal of Creativity in Mental Health · doi:10.1080/15401383.2021.1972885 · Cited by 13 · see citing works
Treating Opioid Use Disorder in General Medical Settings
(2021) · Springer eBooks · doi:10.1007/978-3-030-80818-1 · Cited by 13 · see citing works
Serre, F., Moriceau, S., Donnadieu, L., Forcier, C., Garnier, H., Alexandre, J., Dupuy, L., Philip, P., Levavasseur, Y., de Sevin, É., et al. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1143167 · Cited by 13 · see citing works
Gregory, V. L., Wilkerson, D., Wolfe-Taylor, S. N., Miller, B. L., & Lipsey, A. D. (2024) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2024.2400934 · Cited by 12 · see citing works
Girard, R., Foreman, J., Pinnette, E., Bonar, E. E., Fernandez, A. C., & Lin, L. A. (2023) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000001210 · Cited by 11 · see citing works
Pharmakotherapie der Alkoholentwöhnung: Update und neue Entwicklungen
Soyka, M., & Rösner, S. (2020) · Der Nervenarzt · doi:10.1007/s00115-020-00954-5 · Cited by 11 · see citing works
Angarita, G. A., Hadizadeh, H., Cerdena, I. L., & Potenza, M. N. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1931684 · Cited by 11 · see citing works
Liu, C., & Li, Y. (2023) · Journal of Addictive Diseases · doi:10.1080/10550887.2022.2158664 · Cited by 10 · see citing works
Wen, X., Yang, W., Du, Z., Zhao, J., Li, Y., Yu, D., Zhang, J., Liu, J., & Yuan, K. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.06.035 · Cited by 10 · see citing works
Righetti, R., Cinque, F., Volpe, M. T., & Sebastiani, G. (2024) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2024.2385487 · Cited by 10 · see citing works
Bonner, A. C., Biglan, A., & Drugan-Eppich, K. (2021) · Perspectives on Behavior Science · doi:10.1007/s40614-021-00316-9 · Cited by 10 · see citing works
Addictions treatment mechanisms of change science and implementation science: A critical review
Magill, M., Maisto, S. A., Borsari, B. E., Glass, J. E., Hallgren, K. A., Houck, J. M., Kiluk, B. D., & Kuerbis, A. (2023) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.15053 · Cited by 10 · see citing works
Self-citationThaysen‐Petersen, D., Hammerum, S. K., Vissing, A.-C., Arnfred, B. T., Nordahl, R., Adjorlu, A., Nordentoft, M., Oestrich, I. H., Düring, S. W., & Fink‐Jensen, A. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-068658 · Cited by 10 · see citing works
Behavioral therapies targeting reward mechanisms in substance use disorders
Wardle, M. C., Webber, H. E., Yoon, J. H., Heads, A. M. B., Stotts, A. L., Lane, S. D., & Schmitz, J. M. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173787 · Cited by 10 · see citing works
Fine, S. L., Kane, J. C., Murray, S. M., Skavenski, S. V. W., Paul, R., & Murray, L. K. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108995 · Cited by 10 · see citing works
Alcohol use disorder treatment and outcomes among hospitalized adults with alcoholic hepatitis
Winters, A. C., May, F. P., Wang, Y., Shao, P., Yang, L., & Patel, A. (2021) · Drug and Alcohol Dependence Reports · doi:10.1016/j.dadr.2021.100004 · Cited by 10 · see citing works
Approaching Alcohol Use Disorder After Liver Transplantation for Acute Alcoholic Hepatitis
Ting, P., Gurakar, A. O., Wheatley, J., Chander, G., Cameron, A. M., & Chen, P. (2021) · Clinics in Liver Disease · doi:10.1016/j.cld.2021.03.008 · Cited by 10 · see citing works
Skrzynski, C. J., Karoly, H., Ellingson, J., Hangerty, S., Bryan, A. D., & Hutchison, K. E. (2023) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.21-00392 · Cited by 9 · see citing works
Liu, Y., Manavalan, P., Siddiqi, K. A., Cook, R. L., & Prosperi, M. (2024) · AIDS and Behavior · doi:10.1007/s10461-024-04325-y · Cited by 9 · see citing works
Dual-substance use disorder couples: An integrative review and proposed theoretical model
Kane, L. F., Baucom, D. H., & Daughters, S. B. (2024) · Clinical Psychology Review · doi:10.1016/j.cpr.2024.102447 · Cited by 9 · see citing works
Leary, M., Skinner, J. A., Pursey, K., Verdejo‐García, A., Collins, R. A., Collins, C. E., Hay, P., & Burrows, T. L. (2024) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.13312 · Cited by 9 · see citing works
Durazzo, T. C., Kraybill, E. P., Stephens, L. H., McCalley, D. M., Humphreys, K. N., May, A. C., & Padula, C. B. (2025) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2025.112641 · Cited by 8 · see citing works
Ibragim, A., Issatayeva, B. B., Kuanzhanova, K. T., Mandykayeva, A., & Mambetalina, A. S. (2025) · Acta Psychologica · doi:10.1016/j.actpsy.2025.105052 · Cited by 8 · see citing works
A pilot study on the efficacy of motivational interviewing groups in alcohol use disorders
Csillik, A. S., Devulder, L., Fenouillet, F., & Louville, P. (2021) · Journal of Clinical Psychology · doi:10.1002/jclp.23265 · Cited by 8 · see citing works
Hamonnière, T., & Billieux, J. (2023) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.2827 · Cited by 8 · see citing works
Dickins, K. A., Reed, M., Paun, O., Swanson, B. A., & Karnik, N. S. (2023) · Issues in Mental Health Nursing · doi:10.1080/01612840.2023.2205522 · Cited by 8 · see citing works
Alcohol Dependence, Treatment Seeking, and Treatment Preferences Among Elderly
Jirwe, M., Andréasson, S., & Finn, S. W. (2024) · Journal of Addictions Nursing · doi:10.1097/jan.0000000000000564 · Cited by 8 · see citing works
Technological Interventions for the Treatment of Substance Use Disorders
Schulte, M. H. J., Boumparis, N., Huizink, A. C., & Riper, H. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818697-8.00010-8 · Cited by 8 · see citing works
The Therapeutic Effects of Ketamine in Mental Health Disorders: A Narrative Review
Ramos, C. S., Thornburg, M., Long, K., Sharma, K., Roth, J., Lacatusu, D., Whitaker, R., Pacciulli, D., Loo, S. M., Manzoor, M., et al. (2022) · Cureus · doi:10.7759/cureus.23647 · Cited by 8 · see citing works
Thirty Years of The ASAM Criteria
Gastfriend, D. R., & Mee-Lee, D. (2022) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2022.05.008 · Cited by 8 · see citing works
Cognitive behavioral therapy treatment for drug addiction
Alghamdi, A. A. (2023) · Journal of Addiction Therapy and Research · doi:10.29328/journal.jatr.1001025 · Cited by 8 · see citing works
- Authors
- Magill, M., Ray, L., Kiluk, B., Hoadley, A., Bernstein, M., Tonigan, J. S., & Carroll, K.
- Affiliations
- University of California, Los Angeles (US)
- Yale University (US)
- University of New Mexico (US)
- ORCID
- Venue
- Journal of Consulting and Clinical Psychology
- Published
- 2019-12
- Volume
- 87
- Issue
- 12
- Pages
- 1093-1105
- ISSN
- 0022-006X (ISSN-L)
- 1939-2117
- PMC
- PMC6856400
- OpenAlex
- W2980109357
- Semantic Scholar
- aede69e634a288213fe3b8142a863f778b2960f2
- Cited by
- 315
- References
- 71
- Citations by year
- 2026: 55 · 2025: 54 · 2024: 57 · 2023: 62 · 2022: 37 · 2021: 30 · 2020: 20
- FWCI
- 3.16
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Journal of Consulting and Clinical Psychology (publishedVersion, other-oa)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institute on Alcohol Abuse and Alcoholism (AA026006)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- cognitive behavioral therapy, alcoholism, substance use disorders, treatment efficacy, drinking frequency, alcohol consumption quantity, evidence-based treatment
- MeSH terms
- Alcoholism, Humans, Cognitive Behavioral Therapy, Outcome Assessment, Health Care, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-09-28.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-09-28.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review